Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
Atzpodien, J, Kirchner, H, Rebmann, U, Soder, M, Gertenbach, U, Siebels, M, Roigas, J, Raschke, R, Salm, S, Schwindl, B, Müller, S C, Hauser, S, Leiber, C, Huland, E, Heinzer, H, Siemer, S, Metzner, BVolume:
95
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6603271
Date:
August, 2006
File:
PDF, 122 KB
english, 2006